Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.16746 | 7 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.16847 | 7 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.17092 | 7 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.1282 | 7 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.13363 | 8 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.18654 | 7 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.16205 | 7 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.13504 | 7 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.14825 | 7 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.1596 | 7 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.16133 | 8 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.14413 | 7 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.42551 | 18 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.17323 | 8 |